Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

NCT02579967 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02579967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02579967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Recruiting
Start date
November 19, 2015
Completion date
December 31, 2036
Enrollment
354 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune lymphoproliferative, common variable immunodeficiency, immune system diseases, lymphoproliferative disorders, primary t-cell immunodeficiency disorders